Business Description
IntelliPharmaCeutics International Inc
NAICS : 325412
SIC : 3741
ISIN : CA4581731011
Compare
Compare
Traded in other countries / regions
IPCI.CanadaIPCIF.USAI4AA.Germany IPO Date
1999-07-22Description
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | -8.22 | |||||
| Debt-to-Equity | -0.17 | |||||
| Debt-to-EBITDA | -0.82 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -111.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -75.9 | |||||
| 3-Year EBITDA Growth Rate | 40 | |||||
| 3-Year EPS without NRI Growth Rate | 35.8 | |||||
| 3-Year FCF Growth Rate | 48.5 | |||||
| 3-Year Book Growth Rate | -24.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.52 | |||||
| 9-Day RSI | 51.28 | |||||
| 14-Day RSI | 49.77 | |||||
| 6-1 Month Momentum % | 6.67 | |||||
| 12-1 Month Momentum % | 6.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | |||||
| Quick Ratio | 0.06 | |||||
| Cash Ratio | 0.03 | |||||
| Days Sales Outstanding | 73.44 | |||||
| Days Payable | 78681.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.4 | |||||
| Shareholder Yield % | -18.68 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 98.03 | |||||
| Operating Margin % | -279.12 | |||||
| Net Margin % | -350.12 | |||||
| FCF Margin % | 13.43 | |||||
| ROA % | -205.83 | |||||
| ROIC % | -77.92 | |||||
| ROC (Joel Greenblatt) % | -349.02 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.16 | |||||
| Price-to-Free-Cash-Flow | 11.43 | |||||
| Price-to-Operating-Cash-Flow | 11.43 | |||||
| EV-to-EBIT | -1.33 | |||||
| EV-to-EBITDA | -1.41 | |||||
| EV-to-Revenue | 4.19 | |||||
| EV-to-FCF | 31.41 | |||||
| Price-to-Median-PS-Value | 0.31 | |||||
| Earnings Yield (Greenblatt) % | -75.46 | |||||
| FCF Yield % | 6.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IntelliPharmaCeutics International Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 1.221 | ||
| EPS (TTM) (C$) | -0.124 | ||
| Beta | 1.06 | ||
| Volatility % | 149.07 | ||
| 14-Day RSI | 49.77 | ||
| 14-Day ATR (C$) | 0.000332 | ||
| 20-Day SMA (C$) | 0.08 | ||
| 12-1 Month Momentum % | 6.67 | ||
| 52-Week Range (C$) | 0.04 - 0.135 | ||
| Shares Outstanding (Mil) | 33.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IntelliPharmaCeutics International Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IntelliPharmaCeutics International Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
IntelliPharmaCeutics International Inc Frequently Asked Questions
What is IntelliPharmaCeutics International Inc(TSXV:IPCI)'s stock price today?
The current price of TSXV:IPCI is C$0.08. The 52 week high of TSXV:IPCI is C$0.14 and 52 week low is C$0.04.
When is next earnings date of IntelliPharmaCeutics International Inc(TSXV:IPCI)?
The next earnings date of IntelliPharmaCeutics International Inc(TSXV:IPCI) is .
Does IntelliPharmaCeutics International Inc(TSXV:IPCI) pay dividends? If so, how much?
IntelliPharmaCeutics International Inc(TSXV:IPCI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers